Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 BMC Cancer
1 BMC Gastroenterol
4 J Infect Dis
3 J Viral Hepat
2 J Virol
5 N Engl J Med
1 Pediatr Infect Dis J
1 PLoS Biol
6 PLoS One
1 PLoS Pathog
2 Transplant Proc
1 Transplantation
1 Vaccine
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Cancer

  1. CHEN YH, Wang CC, Chen YY, Wang JH, et al
    Low-dose nivolumab in advanced hepatocellular carcinoma.
    BMC Cancer. 2022;22:1153.
    PubMed         Abstract available

    BMC Gastroenterol

  2. HUANG X, Yan M, Deng Z, Yao L, et al
    Natural history of decompensated cirrhosis with serum hepatitis B DNA < 2000 IU/mL: a retrospective study.
    BMC Gastroenterol. 2022;22:452.
    PubMed         Abstract available

    J Infect Dis

  3. VETTER BN, Reipold EI, Ongarello S, Audu R, et al
    Sensitivity and Specificity of Rapid Diagnostic Tests for Hepatitis C Virus With or Without HIV Coinfection: A Multicentre Laboratory Evaluation Study.
    J Infect Dis. 2022;226:420-430.
    PubMed         Abstract available

  4. OGAWA E, Nomura H, Nakamuta M, Furusyo N, et al
    Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
    J Infect Dis. 2022;226:431-440.
    PubMed         Abstract available

  5. KITABAYASHI J, Shirasaki T, Shimakami T, Nishiyama T, et al
    Upregulation of the Long Noncoding RNA HULC by Hepatitis C Virus and Its Regulation of Viral Replication.
    J Infect Dis. 2022;226:407-419.
    PubMed         Abstract available

  6. SONNEVELD MJ, Hansen BE, Brouwer WP, Chan HL, et al
    Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
    J Infect Dis. 2022;225:1967-1973.
    PubMed         Abstract available

    J Viral Hepat

  7. FELD JJ, Forns X, Dylla DE, Kumada H, et al
    Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts.
    J Viral Hepat. 2022;29:1050-1061.
    PubMed         Abstract available

  8. LEE C, Emeto TI, Walsh N
    Prevalence of hepatitis B virus amongst refugees, asylum seekers and internally displaced persons in low- and middle-income countries: a systematic review.
    J Viral Hepat. 2022 Nov 10. doi: 10.1111/jvh.13770.
    PubMed         Abstract available

  9. PERAZZO H, Silva MST, Coutinho C, Peixoto EM, et al
    Monkeypox outbreak as an opportunity to identify new cases of HCV infection in limited resource settings.
    J Viral Hepat. 2022 Nov 10. doi: 10.1111/jvh.13771.

    J Virol

  10. CHEN Y, Wang B, Ou X, Wu Y, et al
    Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
    J Virol. 2022 Nov 17:e0102022. doi: 10.1128/jvi.01020.
    PubMed         Abstract available

  11. SHIOTA T, Matsuda M, Zheng X, Nagata N, et al
    Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in Ifnar1(-/-) Mice.
    J Virol. 2022 Nov 10:e0149622. doi: 10.1128/jvi.01496.
    PubMed         Abstract available


    WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
    JAMA. 2022;328:1896.

    N Engl J Med

    Children with Acute Hepatitis of Unknown Cause.
    N Engl J Med. 2022;387:1906-1907.

  14. ZENG G, Li H, Zhang Z
    Children with Acute Hepatitis of Unknown Cause.
    N Engl J Med. 2022;387:1907.

  15. DEEP A, Alexander E
    Children with Acute Hepatitis of Unknown Cause.
    N Engl J Med. 2022;387:1907-1908.

  16. KELGERI C, Patel M, Hartley J
    Children with Acute Hepatitis of Unknown Cause. Reply.
    N Engl J Med. 2022;387:1908.

    Children with Acute Hepatitis of Unknown Cause. Reply.
    N Engl J Med. 2022;387:1908-1909.

    Pediatr Infect Dis J

  18. DUVENHAGE J, Draper HR, Garcia-Prats AJ, Winckler J, et al
    Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome.
    Pediatr Infect Dis J. 2022 Sep 6. pii: 00006454-990000000-00179.
    PubMed         Abstract available

    PLoS Biol

  19. BERMUDEZ-MENDEZ E, Bronsvoort KF, Zwart MP, van de Water S, et al
    Incomplete bunyavirus particles can cooperatively support virus infection and spread.
    PLoS Biol. 2022;20:e3001870.
    PubMed         Abstract available

    PLoS One

  20. NAGUIB M, Abdel-Razek W, Estaphan S, Abdelsameea E, et al
    Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C.
    PLoS One. 2022;17:e0276592.
    PubMed         Abstract available

  21. DABROWSKA-LEONIK N, Sawicka-Powierza J, Bernatowska E, Pac M, et al
    Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age.
    PLoS One. 2022;17:e0277473.
    PubMed         Abstract available

  22. ABU EL-MAKAREM MA, Kamel MF, Mohamed AA, Ali HA, et al
    Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
    PLoS One. 2022;17:e0277266.
    PubMed         Abstract available

  23. DAGNEW M, Moges F, Tiruneh M, Million Y, et al
    Molecular diversity of hepatitis B virus among pregnant women in Amhara National Regional State, Ethiopia.
    PLoS One. 2022;17:e0276687.
    PubMed         Abstract available

  24. YEE LM, Shah SK, Grobman WA, Labellarte PZ, et al
    Identifying barriers and facilitators of the inclusion of pregnant individuals in hepatitis C treatment programs in the United States.
    PLoS One. 2022;17:e0277987.
    PubMed         Abstract available

  25. PRONIER C, Bomo J, Besombes J, Genet V, et al
    Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles.
    PLoS One. 2022;17:e0272474.
    PubMed         Abstract available

    PLoS Pathog

  26. MAZOUZ S, Salinas E, Bedard N, Filali A, et al
    Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
    PLoS Pathog. 2022;18:e1010968.
    PubMed         Abstract available

    Transplant Proc

  27. GUTIERREZ-SORIANO L, Gomez JCK, Trujillo NM, Zapata EB, et al
    Postoperative Liver Failure Secondary to Hypoxic Hepatitis in Double Lung Transplantation: A Case Report.
    Transplant Proc. 2022 Nov 9. pii: S0041-1345(22)00701.
    PubMed         Abstract available

  28. TOSHIDA K, Toshima T, Harada N, Nakayama Y, et al
    Autoimmune Hepatitis in an Immunosuppression-Free Patient Who Underwent Living Donor Liver Transplantation From an Identical Twin: A Case Report.
    Transplant Proc. 2022 Nov 14. pii: S0041-1345(22)00684.
    PubMed         Abstract available


  29. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
    DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
    PubMed         Abstract available


  30. RABE APJ, Costello P, Were JJ, Farrer A, et al
    The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset.
    Vaccine. 2022 Oct 21. pii: S0264-410X(22)01263.
    PubMed         Abstract available

    Z Gastroenterol

  31. FICHTL A, Beck A, Seufferlein T, Zizer E, et al
    Pembrolizumab-induced acute exacerbation of hepatitis D.
    Z Gastroenterol. 2022 Nov 14. doi: 10.1055/a-1934-1940.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.